ATE239474T1 - Verwendung von levobupivacain - Google Patents

Verwendung von levobupivacain

Info

Publication number
ATE239474T1
ATE239474T1 AT98935176T AT98935176T ATE239474T1 AT E239474 T1 ATE239474 T1 AT E239474T1 AT 98935176 T AT98935176 T AT 98935176T AT 98935176 T AT98935176 T AT 98935176T AT E239474 T1 ATE239474 T1 AT E239474T1
Authority
AT
Austria
Prior art keywords
levobupivacain
patient
levobupivacaine
anesthetizing
administration
Prior art date
Application number
AT98935176T
Other languages
English (en)
Inventor
Lawrence E Mather
Andrew John Mcglashan Richards
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9715462.9A external-priority patent/GB9715462D0/en
Priority claimed from GBGB9722022.2A external-priority patent/GB9722022D0/en
Priority claimed from GBGB9810427.6A external-priority patent/GB9810427D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of ATE239474T1 publication Critical patent/ATE239474T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrotherapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98935176T 1997-07-22 1998-07-21 Verwendung von levobupivacain ATE239474T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9715462.9A GB9715462D0 (en) 1997-07-22 1997-07-22 levobupivacaine and its use
GBGB9722022.2A GB9722022D0 (en) 1997-10-17 1997-10-17 Levobupivacaine and its use
GBGB9810427.6A GB9810427D0 (en) 1998-05-14 1998-05-14 Levobupivacaine and its use
PCT/GB1998/002170 WO1999004772A2 (en) 1997-07-22 1998-07-21 Use of levobupivacaine

Publications (1)

Publication Number Publication Date
ATE239474T1 true ATE239474T1 (de) 2003-05-15

Family

ID=27268945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98935176T ATE239474T1 (de) 1997-07-22 1998-07-21 Verwendung von levobupivacain

Country Status (12)

Country Link
US (2) US6069155A (de)
EP (1) EP0998287B1 (de)
JP (1) JP2001510795A (de)
AT (1) ATE239474T1 (de)
AU (1) AU739510B2 (de)
BR (1) BR9802537A (de)
CA (1) CA2294921C (de)
DE (1) DE69814394T2 (de)
DK (1) DK0998287T3 (de)
ES (1) ES2198731T3 (de)
PT (1) PT998287E (de)
WO (1) WO1999004772A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376754B1 (en) * 1997-03-07 2002-04-23 Asgrow Seed Company Plants having resistance to multiple herbicides and its use
ES2384094T3 (es) 1997-11-14 2012-06-29 Pacira Pharmaceuticals, Inc. Producción de liposomas multivesiculares
ATE428371T1 (de) 1998-07-17 2009-05-15 Pacira Pharmaceuticals Inc Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
US7805188B2 (en) * 2000-03-24 2010-09-28 Micor, Inc. Anesthesia conduction catheter for delivery of electrical stimulus
CA2403477C (en) * 2000-03-24 2007-07-17 Stephen Brushey Anesthesia conduction catheter
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
NZ529544A (en) * 2001-05-31 2006-11-30 Skyepharma Inc Encapsulation of nanosuspensions in liposomes and microspheres
US7829109B2 (en) * 2001-11-14 2010-11-09 Durect Corporation Catheter injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP2006503004A (ja) * 2002-07-31 2006-01-26 アルザ・コーポレーション 射出可能なデポ組成物及びその使用
DK1539101T3 (da) 2002-07-31 2009-04-27 Alza Corp Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
US20060166182A1 (en) * 2002-12-31 2006-07-27 The Board Of Trustees Of The University Of Ilinois A Body Corporate And Politic Of The State Of Il. Tissue and organ preservation, protection and resuscitation
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
CA2931547A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN116940358A (zh) 2021-01-12 2023-10-24 度勒科特公司 持续释放药物递送系统和有关的方法
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
WO2023064464A1 (en) 2021-10-14 2023-04-20 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
CN119677554A (zh) 2022-05-05 2025-03-21 普络夫有限责任公司 麻醉神经阻滞和方法
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
US5849763A (en) * 1993-10-13 1998-12-15 Darwin Discovery Limited Use of levobupivacaine as an anesthetic agent
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
ES2170179T3 (es) * 1993-10-13 2002-08-01 Darwin Discovery Ltd Agente analgesico y su utilizacion.
DE69628743T2 (de) * 1995-04-13 2004-05-13 Darwin Discovery Ltd., Slough Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
WO1999004772A3 (en) 1999-04-08
EP0998287B1 (de) 2003-05-07
US20020016338A1 (en) 2002-02-07
ES2198731T3 (es) 2004-02-01
DE69814394T2 (de) 2004-03-11
PT998287E (pt) 2003-09-30
EP0998287A2 (de) 2000-05-10
DE69814394D1 (de) 2003-06-12
JP2001510795A (ja) 2001-08-07
CA2294921C (en) 2009-04-07
US6514994B2 (en) 2003-02-04
US6069155A (en) 2000-05-30
CA2294921A1 (en) 1999-02-04
AU8452898A (en) 1999-02-16
WO1999004772A2 (en) 1999-02-04
AU739510B2 (en) 2001-10-11
BR9802537A (pt) 1999-07-20
DK0998287T3 (da) 2003-09-01

Similar Documents

Publication Publication Date Title
ATE239474T1 (de) Verwendung von levobupivacain
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
DE69627228D1 (de) Biokompatible medizinische Elektrodenleitung
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
ATE240730T1 (de) Verwendung von levobupivacaine in gesichtschirugie
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE69821498D1 (de) Verwendung von amifostin
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
AU3401093A (en) Therapeutic agent for threatened abortion
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
TR199901385T2 (xx) Piperidin t�revleri.
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
EA199900006A1 (ru) Препарат и способ для лечения застоной сердечной недостаточности
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
IT9048106A0 (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
EE200100122A (et) R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks
UA18990A (uk) Зубhий імплаhтат
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
UA31266A (uk) Лікувальний засіб "дінальгін"
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу
ITTO920519A1 (it) Sussidio terapeutico dinamico per la rieducazione sensitivo-motoria dell'arto superiore in pazienti cerebrolesi.
BG102009A (en) Method for the treatment of manic and two-pole disease
ITMI20011185A0 (it) Protesi per l'occlusione dell'auricola cardiaca sinistra con impiantotranscatetere
UA915S (uk) Канюля медична

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0998287

Country of ref document: EP